197 related articles for article (PubMed ID: 16543073)
41. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
42. Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association.
Bell SA; Faust H; Mittermüller J; Kolb HJ; Meurer M
Br J Dermatol; 1996 May; 134(5):848-54. PubMed ID: 8736324
[TBL] [Abstract][Full Text] [Related]
43. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease.
Colombo AA; Rusconi C; Esposito C; Bernasconi P; Caldera D; Lazzarino M; Alessandrino EP
Transplantation; 2006 Apr; 81(8):1087-92. PubMed ID: 16641591
[TBL] [Abstract][Full Text] [Related]
44. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
45. Elastin metabolism is disrupted in patients after allogeneic hematopoietic stem cell transplantation (alloHSCT) for acute and chronic myeloid leukemia.
Helbig G; Krzemień S; Francuz T; Wojnar J; Hołowiecki J
Med Sci Monit; 2008 Nov; 14(11):CR584-8. PubMed ID: 18971876
[TBL] [Abstract][Full Text] [Related]
46. Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.
Ratanatharathorn V; Pavletic S; Uberti JP
Cancer Treat Rev; 2009 Dec; 35(8):653-61. PubMed ID: 19682801
[TBL] [Abstract][Full Text] [Related]
47. Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells.
D'Orsogna LJ; Wright MP; Krueger RG; McKinnon EJ; Buffery SI; Witt CS; Staples N; Loh R; Cannell PK; Christiansen FT; French MA
Biol Blood Marrow Transplant; 2009 Jul; 15(7):795-803. PubMed ID: 19539210
[TBL] [Abstract][Full Text] [Related]
48. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P
Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
[TBL] [Abstract][Full Text] [Related]
49. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
50. Acute graft-versus-host disease (aGVHD) presenting with an acquired lupus anticoagulant.
Kharfan-Dabaja MA; Morgensztern D; Santos E; Goodman M; Fernandez HF
Bone Marrow Transplant; 2003 Jan; 31(2):129-31. PubMed ID: 12621495
[TBL] [Abstract][Full Text] [Related]
51. Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation.
Takahashi N; Sato N; Takahashi S; Tojo A
Exp Hematol; 2008 Dec; 36(12):1760-1770. PubMed ID: 18814951
[TBL] [Abstract][Full Text] [Related]
52. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
[TBL] [Abstract][Full Text] [Related]
53. A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease.
Faaij CM; Lankester AC; Spierings E; Hoogeboom M; Bowman EP; Bierings M; Révész T; Egeler RM; van Tol MJ; Annels NE
Br J Haematol; 2006 Jun; 133(5):538-49. PubMed ID: 16681643
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
[TBL] [Abstract][Full Text] [Related]
55. [JAK3 mRNA level in graft versus host disease patients: a preliminary study].
Li QH; Du X; Geng SX; Weng JY; Guo R; Lu ZS; Lin W; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1981-3. PubMed ID: 17923039
[TBL] [Abstract][Full Text] [Related]
56. Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality.
Berger M; Figari O; Bruno B; Raiola A; Dominietto A; Fiorone M; Podesta M; Tedone E; Pozzi S; Fagioli F; Madon E; Bacigalupo A
Bone Marrow Transplant; 2008 Jan; 41(1):55-62. PubMed ID: 17934532
[TBL] [Abstract][Full Text] [Related]
57. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).
Ayyildiz E; Arslan O; Topçuoğlu P; Arat M; Dalva K; Soydan EA; Tol M; Ilhan O
Transfus Apher Sci; 2007 Feb; 36(1):79-85. PubMed ID: 17234454
[TBL] [Abstract][Full Text] [Related]
58. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
59. Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults.
Sugimoto K; Narimatsu H; Kawase T; Iida H; Watanabe M; Kohno A; Kuwatsuka Y; Uchida T; Hamaguchi M; Terakura S; Naoe T; Matsuo K; Murata M; Sawa M; Miyamura K; Morishita Y;
Bone Marrow Transplant; 2008 Apr; 41(8):729-36. PubMed ID: 18176617
[TBL] [Abstract][Full Text] [Related]
60. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
